8132 Egg b. Zurich
Phone: +41 44986 26 28
Fax: +41 44 986 26 30
With roots in the sales of rheumatoid arthritis research products, MD Biosciences (MDB) has assembled a specialized range of products and services to facilitate drug discovery for inflammatory diseases.
Today, MD Biosciences provides several novel models in the area of rheumatoid arthritis (RA) as well as Multiple sclerosis. The in-depth expertise in these disease models has been applied to designing protocols to assess the efficacy and required dosage of novel compounds. We have experience with both small chemical entities as well as in handling and administering biologicals.
MD Biosciences is applying its expertise in other inflammatory diseases as well. Induced arthritis in- vivo models, IBD in -vivo model, asthma in vivo model, Crohns Disease invivo model, mode of actions in-vivo model, are areas where the MDB expertise is being applied.
Besides in vivo, we also offer the complete range of in-vitro assays associated with inflammatory diseases (some examples include multiple assays, tissue culture projects e.g. COX inhibition studies).
Contracted studies are designed and reviewed by MDBs panel of internationally recognized experts and performed at one of MDBs specialized laboratories located in St. Paul, MN (USA), Glasgow (Scotland) or in Israel . We provide a ready team of experts to tackle problems and provide solutions.
We look forward to learning your objectives and to making proposals of how we can help you achieve your breakthroughs!